These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22014302)

  • 1. [Conjugate pneumococcal vaccines and influence on the ear, nose and throat area].
    Almaç A; Kuru FD
    Kulak Burun Bogaz Ihtis Derg; 2011; 21(6):345-8. PubMed ID: 22014302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolving microbiology and molecular epidemiology of acute otitis media in the pneumococcal conjugate vaccine era.
    Pichichero ME; Casey JR
    Pediatr Infect Dis J; 2007 Oct; 26(10 Suppl):S12-6. PubMed ID: 18049375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pneumococcal conjugate vaccine on nasopharyngeal bacterial colonization during acute otitis media.
    Revai K; McCormick DP; Patel J; Grady JJ; Saeed K; Chonmaitree T
    Pediatrics; 2006 May; 117(5):1823-9. PubMed ID: 16651345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States.
    Grijalva CG; Poehling KA; Nuorti JP; Zhu Y; Martin SW; Edwards KM; Griffin MR
    Pediatrics; 2006 Sep; 118(3):865-73. PubMed ID: 16950975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media.
    Cohen R; Levy C; de La Rocque F; Gelbert N; Wollner A; Fritzell B; Bonnet E; Tetelboum R; Varon E
    Pediatr Infect Dis J; 2006 Nov; 25(11):1001-7. PubMed ID: 17072121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predominance of nontypeable Haemophilus influenzae in children with otitis media following introduction of a 3+0 pneumococcal conjugate vaccine schedule.
    Wiertsema SP; Kirkham LA; Corscadden KJ; Mowe EN; Bowman JM; Jacoby P; Francis R; Vijayasekaran S; Coates HL; Riley TV; Richmond P
    Vaccine; 2011 Jul; 29(32):5163-70. PubMed ID: 21621576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?
    van Kempen MJ; Vermeiren JS; Vaneechoutte M; Claeys G; Veenhoven RH; Rijkers GT; Sanders EA; Dhooge IJ
    Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):275-85. PubMed ID: 16140397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 7-Valent pneumococcal conjugate vaccine and otitis media: effectiveness of a 2-dose versus 3-dose primary series.
    Stoecker C; Hampton LM; Moore MR
    Vaccine; 2012 Sep; 30(44):6256-62. PubMed ID: 22906725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine.
    McEllistrem MC; Adams JM; Patel K; Mendelsohn AB; Kaplan SL; Bradley JS; Schutze GE; Kim KS; Mason EO; Wald ER
    Clin Infect Dis; 2005 Jun; 40(12):1738-44. PubMed ID: 15909260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children.
    Kilpi T; Ahman H; Jokinen J; Lankinen KS; Palmu A; Savolainen H; Grönholm M; Leinonen M; Hovi T; Eskola J; Käyhty H; Bohidar N; Sadoff JC; Mäkelä PH;
    Clin Infect Dis; 2003 Nov; 37(9):1155-64. PubMed ID: 14557958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vaccination against acute otitis media].
    Veenhoven RH; van den Berg YL; Schilder AG; Dhooge IJ; Rijkers GT; Sanders EA
    Ned Tijdschr Geneeskd; 2000 May; 144(20):931-4. PubMed ID: 10827848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a pneumococcal conjugate vaccine against acute otitis media.
    Eskola J; Kilpi T; Palmu A; Jokinen J; Haapakoski J; Herva E; Takala A; Käyhty H; Karma P; Kohberger R; Siber G; Mäkelä PH;
    N Engl J Med; 2001 Feb; 344(6):403-9. PubMed ID: 11172176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines.
    Shouval DS; Greenberg D; Givon-Lavi N; Porat N; Dagan R
    Pediatr Infect Dis J; 2009 Apr; 28(4):277-82. PubMed ID: 19258924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infant immunisation with a pneumococcal conjugate vaccine: from the age of two months, for all infants.
    Prescrire Int; 2006 Dec; 15(86):227-33. PubMed ID: 17167934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-based impact of routine infant immunization with pneumococcal conjugate vaccine in the USA.
    Grijalva CG; Griffin MR
    Expert Rev Vaccines; 2008 Feb; 7(1):83-95. PubMed ID: 18251696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the 13-valent pneumococcal conjugate vaccine on the incidences of acute otitis media, recurrent otitis media and tympanostomy tube insertion in children after its implementation into the national immunization program in Turkey.
    Soysal A; Gönüllü E; Yıldız I; Aydemir G; Tunç T; Fırat Y; Erdamar B; Karaböcüoğlu M
    Hum Vaccin Immunother; 2020; 16(2):445-451. PubMed ID: 31424317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of pneumococcal disease in children. Pneumococcal conjugate vaccines: their use globally could have a major impact on public health.
    Kyaw MH; Jones IG; Campbell H
    Acta Paediatr; 2001 May; 90(5):473-6. PubMed ID: 11430703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology of childhood pneumococcal disease in the United States in the era of conjugate vaccine use.
    Toltzis P; Jacobs MR
    Infect Dis Clin North Am; 2005 Sep; 19(3):629-45. PubMed ID: 16102653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Medical indications and effectiveness of the pneumococcal conjugate vaccine].
    Reinert RR
    Laryngorhinootologie; 2006 Apr; 85(4):291-8; quiz 299-300. PubMed ID: 16615030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of pneumococcal vaccination in infants and young children].
    Adam D; Scholz H
    Klin Padiatr; 2001; 213(3):109-13. PubMed ID: 11417363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.